Inhibition of proliferation and migration by piceatannol in vascular smooth muscle cells

Toxicology in Vitro

Volumn 23, Issue 7, 2009, Pages 1284-1291

  Lee, Beobyi ^a   Lee, Eo Jin ^b,c   Kim, Dong Il ^b,c   Park, Sung kyu ^d   Kim, Wun Jae ^c,e   Moon, Sung Kwon ^b,c  

^a Konkuk University School of Medicine   (South Korea)

^b Chungju National University   (South Korea)

^c Chungbuk National University   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

^e Chungbuk National University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Migration; Piceatannol; Proliferation; Vascular smooth muscle cell

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PICEATANNOL; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HEART PROTECTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARDIOTONIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLIN-DEPENDENT KINASES; CYCLINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PHOSPHORYLATION; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

VITACEAE;

EID: 70349446487     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.07.023     Document Type: Article

References (39)

1. Abedi H., and Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc. Res. 30 (1995) 544-556
2. Ashikawa K., Majumdar S., Banerjee S., Bharti A.C., Shishodia S., and Aggarwal B.B. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol. 169 11 (2002) 6490-6497
3. Auge N., Maupas-Schwalm F., Elbaz M., Thiers J.C., Waysbort A., Itohara S., Krell H.W., Salvayre R., and Nègre-Salvayre A. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110 (2004) 571-578
4. Bendeck M.P., Zempo N., Clowes A.W., Galardy R.E., and Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75 (1994) 539-545
5. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc. Res. 50 3 (2001) 556-565
6. Chandrasekar B., Mummidi S., Mahimainathan L., Patel D.N., Bailey S.R., Imam S.Z., Greene W.C., and Valente A.J. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J. Biol. Chem. 281 (2006) 15099-15109
7. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., and Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18 (1999) 1571-1583
8. Cho A., and Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ. Res. 91 9 (2002) 845-851
9. Farina A.R., Tacconelli A., Vacca A., Maroder M., Gulino A., and Mackay A.R. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH Neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor NF-κB elements. Cell Growth Diff. 10 (1999) 353-367
10. Geahlen R.L., and McLaughlin J.L. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 165 1 (1989) 241-245
11. Goetze S., Xi X.P., and Kawano Y. TNF-α-induced migration of vascular smooth muscle cells is MAPK-dependent. Hypertension 33 (1999) 183-189
12. Goetze U., Kintscher K., Kaneshiro W.P., Meehan A., Collins E., Fleck W.A., Hsueh W.A., and Law R.E. TNF-α induces expression of transcription factors c-fos Egr-1 and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 159 (2001) 93-101
13. Hanke H. Proliferative response of smooth muscle cells after experimental balloon angioplasty. Circulation 93 1 (1996) 202
14. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 16 (2005) 1685-1695
15. Hoefer I.E., van Royen N., Rectenwald J.E., Bray E.J., Abouhamze Z., Moldawer L.L., Voskuil M., Piek J.J., Buschmann I.R., and Ozaki C.K. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 105 14 (2002) 1639-1641
16. Horvath C., Welt F.G., Nedelman M., Rao P., and Rogers C. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ. Res. 90 4 (2002) 488-494
17. Hu P.P., Shen X., Huang D., Liu Y., Counter C., and Wang X.F. The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J. Biol. Chem. 274 (1999) 35381-35387
18. Jorda M., Olmeda D., Vinyals A., Valero E., Cubillo E., Llorens A., Cano A., and Fabra A. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J. Cell Sci. 118 (2005) 3371-3385
19. Kim H.M., Bae S.J., Kim D.W., Kim B.K., Lee S.B., Lee U.S., Kim C.H., and Moon S.K. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Int. Immunopharmacol. 7 8 (2007) 1083-1091
20. Kim H.J., Lee K.W., Kim M.S., and Lee H.J. Piceatannol attenuates hydrogen-peroxide- and peroxynitrite-induced apoptosis of PC12 cells by blocking down-regulation of Bcl-XL and activation of JNK. J. Nutr. Biochem. 19 7 (2008) 459-466
21. Kuo P.L., and Hsu Y.L. The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Mol. Nutr. Food Res. 52 4 (2008) 408-418
22. Larrosa M., Tomás-Barberán F.A., and Espín J.C. The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur. J. Nutr. 43 5 (2004) 275-284
23. Libby P. Inflammation in atherosclerosis. Nature 420 6917 (2002) 868-874
24. Macleod K., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., and Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9 (1995) 935-944
25. Moon S.K., Thompson L.J., Madamanchi N., Ballinger S., Papaconstantinou J., Horaist C., Runge M.S., and Patterson C. Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 280 6 (2001) H2779-2788
26. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., Madamanchi N.R., and Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 301 (2003) 1069-1078
27. Moon S.K., Cha B.Y., and Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J. Cell. Physiol. 2004 198 (2004) 417-427
28. Oak M.H., El Bedoui J., Anglard P., and Schini-Kerth V.B. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 110 13 (2004) 1861-1867
29. Okamoto E., Couse T., De Leon H., Vinten-Johansen J., Goodman R.B., Scott N.A., and Wilcox J.N. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 104 18 (2001) 2228-2235
30. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
31. Sato H., Kita M., and Seiki M. V-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements, a mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268 (1993) 23460-23468
32. Seow C.J., Chue S.C., and Wong W.S. Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro. Eur. J. Pharmacol. 443 1-3 (2002) 189-196
33. Sherr C.J. G1 phase progression: cycling on cue. Cell 79 (1994) 551-555
34. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 12 (1999) 1501-1512
35. Srivastava A.K., Qin X., Wedhas N., Arnush M., Linkhart T.A., Chadwick R.B., and Kumar A. Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J. Biol. Chem. 282 48 (2007) 35113-35124
36. Toyoshima H., and Hunter T. P27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78 (1994) 67-74
37. Weiss R.H., Joo A., and Randour C. P21Waf1/Cip1 is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 275 (2000) 10285-10290
38. Wolter F., Clausnitzer A., Akoglu B., and Stein J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J. Nutr. 132 (2002) 298-302
39. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., and Beach D. P21 is a universal inhibitor of cyclin kinases. Nature 366 (1993) 701-704